FGF21 and metabolic dysfunction-associated steatotic liver disease: However, as the first study on Saudi T2DM patients, our study shows a strong relationship between NAFLD and the level of FGF-21, suggesting its use as a possible biomarker for predicting NAFLD, thus helping to plan future research.